Biocair, at this point in time, and until the end of 2020, anticipates no real changes to trade or regulations between the UK and EU in the life sciences logistics sector.
As 2020 progresses we should begin to get a better idea on what to expect from 2021. If the situation should change during this time we will be working closely with the authorities and our customers to ensure the pharmaceutical supply chain is adequately prepared.
What has happened and what is expected to happen?
The UK stopped being a member of the EU on 31 January 2020. While the UK has agreed the terms of its EU departure, both sides still need to decide what their future relationship will look like.
This will be worked out during the transition period, which begins immediately after Brexit day and is due to end on 31 December 2020.
During this transition period the UK will continue to follow all of the EU’s rules and its trading relationship will remain the same, whilst the UK Government will attempt to negotiate a comprehensive trade deal with the EU. If this trade deal is not concluded by the end of the transition period (end December 2020) the Government has indicated that they will progress with a hard Brexit, with the UK leaving the EU without a trade deal on 1 January 2021.
Biocair is fully engaged in the Brexit process and has detailed plans in place. Since the Brexit vote Biocair has:
• Hosted a series of Brexit workshops
• Created a strategic Brexit team involving key personnel from all departments
• Conducted a thorough impact analysis
• Worked with key authorities to have our say on behalf of our customers
We will continue to:
• Remain fully engaged in the Brexit process
• Host Brexit workshops for our customers
• Publish regular updates
If you are concerned or would like to discuss particular challenges or requirements you may have, please email Biocair’s dedicated Brexit team via email@example.com or contact your local Biocair office.